According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

The U.S. healthcare system, built on binary disease definitions, is not prepared to handle the complexities of weight loss ...

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

Can medications associated with comorbidities ... How should the presence of diabetic kidney disease affect current clinical management of diabetes? 16. Do novel kidney disease CVD pathways ...

In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Doctors now regularly prescribe SGLT-2 inhibitors to treat diabetes if their current medication is not controlling their condition adequately. Currently, around 1 in 10 people in the U.S. with ...

Dr. Luba Yammine is investigating a treatment that could help smokers both quit and sidestep the weight gain that could stand ...

Amycretin, a dual pathway, oral weight loss drug, was found to be safe and tolerable in a phase 1 study and led to weight loss of up to 13% in people with overweight and obesity.

Health Minister Mark Holland urged a committee of senators Wednesday not to tweak the pharmacare bill he carefully negotiated with the NDP earlier this year. The bill would underpin a potential ...